CASP4 and Alzheimer disease: Overall, targeting the caspase-4 pathway may offer a promising therapeutic strategy to reduce P. gingivalis-LPS-induced neurotoxicity linked to AD and ADRD, and identifying specific molecular targets will be crucial in the development of future treatments aimed at alleviating these conditions.